SS
HAE icon

Sunbelt Securities’s Haemonetics HAE Stock Holding History

Sunbelt Securities’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$676 Hold
12
– – ﹤0.01% 2202
2025
Q4 		$962 Buy
+12
New +$806 ﹤0.01% 2069

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sunbelt Securities's HAE Position: Q1 2026 in Review

Sunbelt Securities held its Haemonetics (HAE) position steady in Q1 2026 at 12 shares worth $676. The position accounts for ﹤0.01% of the portfolio, ranked #2202.

Sunbelt Securities first reported a position in HAE in Q4 2025 and has held it in 2 quarters since. The position peaked at $962 in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Sunbelt Securities held 12 shares of Haemonetics worth $676 as of Q1 2026.
  • Sunbelt Securities left its Haemonetics share count unchanged in Q1 2026.
  • Haemonetics made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2202 holding.
  • Sunbelt Securities first reported a position in Haemonetics in Q4 2025 and has held it in 2 quarters since.
  • Sunbelt Securities's Haemonetics position peaked at $962 in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.